Xerion Healthcare Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Liquidation
Xerion Healthcare General Information
Description
Developer of nanomedicine technology designed to improve the effectiveness of conventional radiotherapy while minimizing side effects. The company's method is based on titanium dioxide injected into tumors before standard radiotherapy which enhances the effectiveness of the treatment by amplifying the dose of free radicals generated by the X-rays, enabling medical professionals to treat dense tumors.
Contact Information
Website
www.xerionhealthcare.co.ukCorporate Office
- Care of James Cowper Kreston The White Building
- 1-4 Cumberland Place
- Southampton SO15 2NP
- England, United Kingdom
Corporate Office
- Care of James Cowper Kreston The White Building
- 1-4 Cumberland Place
- Southampton SO15 2NP
- England, United Kingdom
Xerion Healthcare Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Bankruptcy: Liquidation | 15-May-2024 | Completed | Bankruptcy: Liquidation | |||
11. Secondary Transaction - Private | Completed | Generating Revenue | ||||
10. Grant | 01-Oct-2022 | Completed | Generating Revenue | |||
9. Later Stage VC | 03-Nov-2021 | Completed | Generating Revenue | |||
8. Grant | 01-Dec-2020 | Completed | Generating Revenue | |||
7. Later Stage VC (Series A) | 08-Apr-2020 | Completed | Generating Revenue | |||
6. Grant | 20-Sep-2019 | Completed | Generating Revenue | |||
5. Early Stage VC (Series A) | 14-Mar-2018 | Completed | Generating Revenue | |||
4. Grant | 24-Mar-2017 | $297K | $2.87M | Completed | Generating Revenue | |
3. Early Stage VC | 17-Oct-2016 | $530K | $2.87M | Completed | Startup |
Xerion Healthcare Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 560,320 | $0.001369 | $2.85 | $2.85 | 1x | $2.85 | 22.92% |
Xerion Healthcare Patents
Xerion Healthcare Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-201719076-D0 | Particles for the treatment of cancer in combination with radiotherapy | Inactive | 17-Nov-2017 | ||
EP-3710056-A1 | Particles for the treatment of cancer in combination with radiotherapy | Pending | 17-Nov-2017 | ||
US-20200276230-A1 | Particles for the treatment of cancer in combination with radiotherapy | Inactive | 17-Nov-2017 | ||
JP-2021503492-A | Particles for treating cancer in combination with radiation therapy | Pending | 17-Nov-2017 | ||
GB-201612841-D0 | Nanoparticles for the treatment of cancer in combination with internal radiation therapy | Inactive | 25-Jul-2016 |
Xerion Healthcare Signals
Xerion Healthcare FAQs
-
When was Xerion Healthcare founded?
Xerion Healthcare was founded in 2015.
-
Where is Xerion Healthcare headquartered?
Xerion Healthcare is headquartered in Southampton, United Kingdom.
-
What is the size of Xerion Healthcare?
Xerion Healthcare has 5 total employees.
-
What industry is Xerion Healthcare in?
Xerion Healthcare’s primary industry is Drug Discovery.
-
Is Xerion Healthcare a private or public company?
Xerion Healthcare is a Private company.
-
What is Xerion Healthcare’s current revenue?
The current revenue for Xerion Healthcare is
. -
How much funding has Xerion Healthcare raised over time?
Xerion Healthcare has raised $6.35M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »